Slimming Beauty warning
This article was originally published in The Tan Sheet
Executive Summary
FDA warns consumers not to take Slimming Beauty Bitter Orange Slimming Capsules because they contain undeclared sibutramine. The prescription weight-loss ingredient is particularly dangerous to people with heart conditions. Abbott Laboratories announced Oct. 8 it is taking prescription sibutramine (Meridia) off the market. Slimming Beauty is made by Beautiful Health, Inc. and was sold online and distributed at community events, FDA has issued multiple warnings about tainted supplements (1"The Tan Sheet" July 26, 2010, In Brief)
You may also be interested in...
FDA issues adulterated supplement warnings
FDA warns consumers to stop taking Slim-30 Herb Supplement, a weight- loss supplement that contains undeclared sibutramine. Sibutramine is an FDA-approved product, but the agency has not approved Slim-30 Herb Supplements, so its safety in the product is unknown. Sibutramine may present a "significant risk" to patients with congestive heart failure, stroke or other cardiac conditions, FDA says. The agency also warns consumers not to take Joyful Slim Herb Supplement, marketed by J&H Besta Corp., because it contains undeclared desmethyl sibutramine. The company announced July 22 a recall of product lot 101408 including 30-count bottles with the UPC 897966002007. In addition, Good Health Inc. recalls Vialipro, a product marketed as a supplement for sexual enhancement. The firm said July 16 that FDA found sulfoaildenafil, an analogue of the pharmaceutical ingredient sildenafil, in certain batches. FDA previously warned of criminal charges for undeclared pharmaceuticals in OTC drugs, and has issued warnings leading to recalls of tainted supplements
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.